Lotus Eye Hospital and Institute Limited has informed the Exchange with copy of minutes of Annual General Meeting held on September 17, 2021
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lotus Eye Hospital held its 28th AGM on September 17, 2025, chaired by Ms. Kavetha Sundaramoorthy with 71 members present via video conferencing. For FY 2024-25, the company reported a slight increase in turnover from Rs 48.21 crore to Rs 49.56 crore, while net profit stood at Rs 73.93 lakhs (a thin margin of 1.459%). Total expenses rose by Rs 3.99 crore mainly due to the opening of a new branch at Karur on July 12, 2024, which is the company's 9th center. The company invested Rs 5.57 crore in capital assets during the year. All four ordinary business resolutions were passed with over 99% shareholder approval, including adoption of audited financials, re-appointment of Dr. Kavetha Sundaramoorthy as director, appointment of secretarial auditors for 5 years, and approval of Rs 1 lakh remuneration for non-executive director KS Ramalingam.
Revenue growth was marginal (~2.8%) while net profit margin remained very thin at under 1.5%, suggesting the company's expansion drive is weighing on profitability in the near term. The strong shareholder backing (>99% on all resolutions) signals confidence in management, and the CFO's positive outlook for FY 2025-26 may support sentiment, but investors should watch for margin recovery as new centers mature.